Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REMIfentanil vs Succinylcholine and Rocuronium for Intubation in Spine Surgery
NCT07835295Phase 4Not yet recruiting
- Sponsor
- Mayo Clinic
- Start
- Sep 2026
- Primary completion
- Sep 2028
- Countries
- 1
01
Overview
A Phase 4 trial of remifentanil, sponsored by Mayo Clinic. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
remifentanil
Beyond the preview
Go deeper on NCT07835295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07835295.